Cleared Traditional

K220254 - Neuron-Spectrum-AM with Neuron-Spectrum.NET Software (FDA 510(k) Clearance)

Nov 2022
Decision
303d
Days
Class 2
Risk

K220254 is an FDA 510(k) clearance for the Neuron-Spectrum-AM with Neuron-Spectrum.NET Software. This device is classified as a Non-normalizing Quantitative Electroencephalograph Software (Class II - Special Controls, product code OLT).

Submitted by Neurosoft , Ltd. (Ivanovo, RU). The FDA issued a Cleared decision on November 30, 2022, 303 days after receiving the submission on January 31, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Analyze Electroencephalograph Data Using Conventional Methodology To Output And Display Standard Electroencephalograph Parameters For Interpretation By A Qualified User..

Submission Details

510(k) Number K220254 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2022
Decision Date November 30, 2022
Days to Decision 303 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OLT - Non-normalizing Quantitative Electroencephalograph Software
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Analyze Electroencephalograph Data Using Conventional Methodology To Output And Display Standard Electroencephalograph Parameters For Interpretation By A Qualified User.